Literature DB >> 25113856

pANCA-vasculitis associated with rectal adenocarcinoma.

C Hommel, Z Rihova, F Mokaddem, B Libotte.   

Abstract

We report the case of a 69-year-old male patient who was admitted for fever, dry cough, recurrent sinusitis with epistaxis, anorexia with weight loss of 20 kg over a 3-month period, myalgia, and mononeuritis multiplex. He was diagnosed with pANCA/anti-MPO associated vasculitis and rectal adenocarcinoma. The tumor was treated by surgical resection. Recurrence of vasculitis occurred during steroid tapering which prompted us to add Mycophenolate mofetyl. A complete remission was achieved. We conclude that in the present case the vasculitis was an independent disease, not a paraneoplastic phenomenon. We discuss the value of different ANCA serologies for diagnostics and follow-up, the epidemiology of vasculitis associated with malignancy, and the concept of vasculitis as a paraneoplastic syndrome.

Entities:  

Keywords:  ANCA-associated vasculitis,; Cancer-associated vasculitis,; Granulomatosis with polyangiitis; Microscopic polyangiitis,; Paraneoplastic syndrome,

Mesh:

Substances:

Year:  2014        PMID: 25113856     DOI: 10.1179/2295333714Y.0000000064

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  2 in total

1.  Paraneoplastic vasculitis associated to pelvic chondrosarcoma: a case report.

Authors:  Camilla Arvinius; Ana González-Pérez; Javier García-Coiradas; Roberto García-Maroto; Juan Luis Cebrián-Parra
Journal:  SICOT J       Date:  2016-02-26

2.  Simultaneous Occurrence of Sarcoidosis and Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis in a Patient with Lung Cancer.

Authors:  Kazuo Tsuchiya; Masato Karayama; Taichi Sato; Hideki Yasui; Hironao Hozumi; Yuzo Suzuki; Kazuki Furuhashi; Noriyuki Enomoto; Tomoyuki Fujisawa; Yutaro Nakamura; Naoki Inui; Haruhiko Sugimura; Hideo Yasuda; Takafumi Suda
Journal:  Intern Med       Date:  2019-07-22       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.